CN209154217U - A new type of medical hydrogel composite dressing - Google Patents
A new type of medical hydrogel composite dressing Download PDFInfo
- Publication number
- CN209154217U CN209154217U CN201821735584.7U CN201821735584U CN209154217U CN 209154217 U CN209154217 U CN 209154217U CN 201821735584 U CN201821735584 U CN 201821735584U CN 209154217 U CN209154217 U CN 209154217U
- Authority
- CN
- China
- Prior art keywords
- layer
- hydrogel
- thickness
- sorptivety
- bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 73
- 239000002131 composite material Substances 0.000 title description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 56
- 239000003814 drug Substances 0.000 claims abstract description 27
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 7
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract description 6
- 239000011505 plaster Substances 0.000 claims abstract 2
- 230000002745 absorbent Effects 0.000 claims description 7
- 239000002250 absorbent Substances 0.000 claims description 7
- 229960003022 amoxicillin Drugs 0.000 claims description 5
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims description 5
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 238000004026 adhesive bonding Methods 0.000 claims description 3
- 229960000723 ampicillin Drugs 0.000 claims description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 238000007731 hot pressing Methods 0.000 claims description 3
- -1 polypropylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 229920006264 polyurethane film Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims 2
- 239000002861 polymer material Substances 0.000 claims 2
- 241000206575 Chondrus crispus Species 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 30
- 208000027418 Wounds and injury Diseases 0.000 abstract description 30
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 230000029663 wound healing Effects 0.000 abstract description 11
- 230000023597 hemostasis Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940116977 epidermal growth factor Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 118
- 229940079593 drug Drugs 0.000 description 13
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920001222 biopolymer Polymers 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域technical field
本实用新型属于医用水敷料技术领域,具体涉及一种新型医用水凝胶复合敷料。The utility model belongs to the technical field of medical water dressings, in particular to a novel medical hydrogel composite dressing.
背景技术Background technique
传统医用敷料如医用脱脂棉,纱布等,具有网状结构,制作工艺简单,适用范围广,原料来源广泛,价格低廉,对伤口渗出液有较好吸收作用,并对伤口有一定保护作用。但传统医用敷料也有着明显缺点,伤口不能保持湿润,不利于伤口愈合,更换敷料时伤口粘连,损伤新生肉芽组织并引起疼痛,抗菌能力差,易感染,止血效果差。Traditional medical dressings, such as medical absorbent cotton, gauze, etc., have a mesh structure, a simple production process, a wide range of applications, a wide range of raw materials, low prices, good absorption of wound exudate, and a certain protective effect on wounds. However, traditional medical dressings also have obvious shortcomings. The wound cannot be kept moist, which is not conducive to wound healing. When the dressing is changed, the wound adheres, damages the new granulation tissue and causes pain, and has poor antibacterial ability, easy infection, and poor hemostatic effect.
为了保持创面的湿润,逐渐出现了以水凝胶为基底的敷料,水凝胶具有独特的三维网状结构,能有效将水分锁定在其中,使水凝胶的含水量能够高达95%以上,且能缓慢释放水分,保持创面的微湿环境,促进创面愈合,而且水凝胶通常还具有一定的吸液能力,能缓慢吸收创面渗液,然而,由于水凝胶类敷料的吸液速率较低,不能满足创面初期渗出较多的护理阶段,需要更换水凝胶,这大大限制了这类敷料在临床应用。In order to keep the wound moist, hydrogel-based dressings have gradually appeared. The hydrogel has a unique three-dimensional network structure, which can effectively lock the water in it, so that the water content of the hydrogel can be as high as 95%. Moreover, it can slowly release water, maintain the slightly moist environment of the wound, and promote wound healing. Moreover, the hydrogel usually has a certain ability to absorb liquid and can slowly absorb the wound exudate. It can not meet the nursing stage with more exudation in the early stage of the wound, and the hydrogel needs to be replaced, which greatly limits the clinical application of this type of dressing.
在伤口愈合过程中通常还需要防止细菌感染,传统的方式是在伤口上额外施用抗菌药物后再用敷料覆盖伤口和药物,操作使用复杂,因此逐渐出现了将抗菌剂负载在敷料上,实现敷料对伤口的直接抗菌作用。In the process of wound healing, it is usually necessary to prevent bacterial infection. The traditional method is to apply additional antibiotics to the wound and then cover the wound and the medicine with a dressing. The operation and use are complicated. Therefore, it gradually appears that the antibacterial agent is loaded on the dressing to realize dressing. Direct antibacterial effect on wounds.
因此研究开发出一种能够为创面创造封闭的润湿环境、促进伤口愈合,并且抗菌止血功效显著,同时可消除异味的功能性复合敷料,成为了目前亟待解决的技术问题。Therefore, research and development of a functional composite dressing that can create a closed wetting environment for the wound surface, promote wound healing, and have significant antibacterial and hemostatic effects, and can eliminate odors, has become an urgent technical problem to be solved.
实用新型内容Utility model content
发明目的:针对现有技术存在的不足,本实用新型的目的是提供一种新型医用水凝胶复合敷料。Purpose of the invention: Aiming at the deficiencies in the prior art, the purpose of this utility model is to provide a novel medical hydrogel composite dressing.
技术方案:为了实现上述发明目的,本实用新型采用的技术方案如下:Technical scheme: In order to realize the above-mentioned purpose of the invention, the technical scheme adopted by the present utility model is as follows:
一种新型医用水凝胶复合敷料,包括由内层向外层依次设置的离型纸层、填药层、抗菌水凝胶层、吸渗缓冲层、透气层和背衬层,所述填药层为嵌入抗菌水凝胶层的多个间隔排列的条状结构,所述填药层的一面紧贴离型纸层,其余表面嵌入抗菌水凝胶层内,所述抗菌水凝胶层一面紧贴离型纸层,另一面与吸渗缓冲层连接。A novel medical hydrogel composite dressing, comprising a release paper layer, a drug filling layer, an antibacterial hydrogel layer, an absorption buffer layer, a breathable layer and a backing layer sequentially arranged from an inner layer to an outer layer. The drug layer is a plurality of strip-like structures embedded in the antibacterial hydrogel layer, one side of the drug filling layer is close to the release paper layer, and the other surfaces are embedded in the antibacterial hydrogel layer, and the antibacterial hydrogel layer One side is close to the release paper layer, and the other side is connected with the absorption buffer layer.
作为优选,所述填药层的截面呈拱形,在所述填药层内填充有促表皮生长因子EGF和止血膏。Preferably, the cross-section of the drug-filled layer is arched, and the epidermal growth factor EGF and hemostatic ointment are filled in the drug-filled layer.
作为优选,所述抗菌水凝胶层为生物高分子材料制成的抗菌水凝胶层,所述生物高分子材料为卡拉胶、壳聚糖或者纤维素,在所述抗菌水凝胶层内设置有阿莫西林或者氨苄西林。Preferably, the antibacterial hydrogel layer is an antibacterial hydrogel layer made of a biopolymer material, and the biopolymer material is carrageenan, chitosan or cellulose, within the antibacterial hydrogel layer Set with amoxicillin or ampicillin.
作为优选,所述抗菌水凝胶层和吸渗缓冲层的连接面为相互啮合的齿轮状结构。Preferably, the connection surface of the antibacterial hydrogel layer and the absorbing buffer layer is a gear-like structure that meshes with each other.
作为优选,所述吸渗缓冲层为高吸水性树脂,所述透气层为聚氨酯薄膜,所述背衬层为医用聚丙烯或无纺布制成的医用胶布,所述离型纸层为PET或离型纸片,在所述离型纸片中间设有剥离切口。Preferably, the absorption buffer layer is a superabsorbent resin, the breathable layer is a polyurethane film, the backing layer is a medical tape made of medical polypropylene or non-woven fabric, and the release paper layer is PET Or a release paper sheet, and a peeling cut is provided in the middle of the release paper sheet.
作为优选,所述抗菌水凝胶层、吸渗缓冲层、透气层和背衬层,其相邻两层之间为胶黏和/或热压的形式复合连接成型。Preferably, the antibacterial hydrogel layer, the absorbent buffer layer, the breathable layer and the backing layer are formed by composite connection between two adjacent layers in the form of gluing and/or hot pressing.
作为优选,所述背衬层的尺寸不小于透气层的尺寸,所述透气层的尺寸不小于吸渗缓冲层的尺寸,所述离型纸层的尺寸不小于抗菌水凝胶层的尺寸。Preferably, the size of the backing layer is not smaller than the size of the breathable layer, the size of the breathable layer is not smaller than the size of the absorbent buffer layer, and the size of the release paper layer is not smaller than the size of the antibacterial hydrogel layer.
作为优选,所述离型纸层的边缘超出对应的抗菌水凝胶层应边缘1-2cm。Preferably, the edge of the release paper layer should exceed the edge of the corresponding antibacterial hydrogel layer by 1-2 cm.
作为优选,所述离型纸层的厚度为0.1-2mm,所述填药层厚度为0.3-1.2mm,所述抗菌水凝胶层厚度为1.5-5mm,所述吸渗缓冲层的厚度为1-5mm,所述透气层厚度为0.5-2mm,所述背衬层厚度为0.5-4mm。Preferably, the thickness of the release paper layer is 0.1-2mm, the thickness of the drug filling layer is 0.3-1.2mm, the thickness of the antibacterial hydrogel layer is 1.5-5mm, and the thickness of the absorption buffer layer is 1-5mm, the thickness of the breathable layer is 0.5-2mm, and the thickness of the backing layer is 0.5-4mm.
作为优选,所述离型纸层厚度为0.35mm,所述填药层厚度为0.8mm,所述抗菌水凝胶层的厚度为2mm,所述吸渗缓冲层的厚度为3mm,所述透气层的厚度为2mm,所述背衬层的厚度为2mm。Preferably, the thickness of the release paper layer is 0.35mm, the thickness of the drug filling layer is 0.8mm, the thickness of the antibacterial hydrogel layer is 2mm, the thickness of the absorption buffer layer is 3mm, and the thickness of the breathable layer is 3mm. The thickness of the layer was 2 mm and the thickness of the backing layer was 2 mm.
有益效果:与现有技术相比,本实用新型具有以下优点:Beneficial effect: Compared with the prior art, the utility model has the following advantages:
1、快速而强大的渗出液吸收能力;1. Fast and powerful absorption capacity of exudate;
2、透性低,使创面保持湿润,避免更换敷料时发生再次性机械性损伤;2. Low permeability, keeping the wound moist and avoiding repeated mechanical damage when changing dressings;
3、使用方便、顺应性好,可适合身体各个部位;3, easy to use, good compliance, suitable for all parts of the body;
4、隔热保温、缓冲外界冲力;4, heat insulation, buffer external impact;
5、GF促进伤口愈合,减少伤疤产生5. GF promotes wound healing and reduces scarring
6、止血,抗菌,防止感染。6, hemostasis, antibacterial, prevent infection.
本实用的型医用水凝胶复合敷料中的抗菌水凝胶层与伤口直接接触起到保护,促进愈合,防止感染减轻痛等治疗作用,当抗菌水凝胶层所吸收的伤口液体到一定量时自动由吸渗缓冲层吸收,以保证伤口处保持良好的湿润环境,其吸渗缓冲层吸渗力强而且具有极佳的弹性和适应性,能够很好的缓解在外力作用下对伤口的损伤。填药层中EGF促进伤口愈合,减少伤疤的产生,止血膏有利于伤口止血愈合。The antibacterial hydrogel layer in the medical hydrogel composite dressing of the utility model is in direct contact with the wound to protect, promote healing, prevent infection and relieve pain and other therapeutic effects. When the wound liquid absorbed by the antibacterial hydrogel layer reaches a certain amount It is automatically absorbed by the absorbent buffer layer to ensure that the wound maintains a good moist environment. The absorbent buffer layer has strong absorbing power and excellent elasticity and adaptability, which can well relieve the wound caused by external force. damage. EGF in the filling layer promotes wound healing and reduces the generation of scars, and hemostatic ointment is beneficial to wound hemostasis and healing.
附图说明Description of drawings
图1是新型医用水凝胶复合敷料结构示意图;Fig. 1 is a schematic diagram of the structure of a new type of medical hydrogel composite dressing;
图2是新型医用水凝胶复合敷料结构示意图。Figure 2 is a schematic diagram of the structure of the new medical hydrogel composite dressing.
具体实施方式Detailed ways
下面结合附图进一步阐明本实用新型。The present utility model is further explained below in conjunction with the accompanying drawings.
如图1和2所示,定义靠近皮肤的一侧为内层,本申请的新型医用水凝胶复合敷料,包括由内层向外层依次设置的离型纸层1、填药层2、抗菌水凝胶层3、吸渗缓冲层4、透气层5和背衬层6,填药层2为嵌入抗菌水凝胶层3的多个间隔排列的条状结构,填药层2的一面紧贴离型纸层1,其余表面嵌入抗菌水凝胶层3内,抗菌水凝胶层3一面紧贴离型纸层1,另一面与吸渗缓冲层4连接。使用时,将离型纸层1从敷料上撕下,弃去不用,填药层2与抗菌水凝胶层3和创面充分接触。As shown in Figures 1 and 2, the side close to the skin is defined as the inner layer, and the novel medical hydrogel composite dressing of the present application comprises a release paper layer 1, a drug filling layer 2, The antibacterial hydrogel layer 3, the absorption buffer layer 4, the breathable layer 5 and the backing layer 6, the drug filling layer 2 is a plurality of spaced strip structures embedded in the antibacterial hydrogel layer 3, and one side of the drug filling layer 2 The antibacterial hydrogel layer 3 is closely attached to the release paper layer 1 on one side, and the other side is connected to the absorption buffer layer 4 . When in use, the release paper layer 1 is torn off from the dressing and discarded, and the drug filling layer 2 is in full contact with the antibacterial hydrogel layer 3 and the wound surface.
填药层2的截面呈拱形,在填药层2内填充有促表皮生长因子EGF和止血膏,止血膏可采用巴曲亭。由EGF和巴曲亭组成的填药层2与创面充分接触,止血和促进伤口的愈合,减少疤痕的产生。The cross section of the medicine filling layer 2 is arched, and the medicine filling layer 2 is filled with epidermal growth factor EGF and hemostatic ointment. The drug filling layer 2 composed of EGF and bacitretin is in full contact with the wound surface to stop bleeding, promote wound healing, and reduce the generation of scars.
抗菌水凝胶层3为生物高分子材料制成的抗菌水凝胶层3,生物高分子材料为卡拉胶、壳聚糖或者纤维素,在抗菌水凝胶层3内设置有阿莫西林或者氨苄西林等青霉素类药物。The antibacterial hydrogel layer 3 is an antibacterial hydrogel layer 3 made of a biopolymer material, the biopolymer material is carrageenan, chitosan or cellulose, and amoxicillin or amoxicillin is arranged in the antibacterial hydrogel layer 3. Penicillins such as ampicillin.
。本实例的抗菌性水凝胶3由生物高分子卡拉胶添加阿莫西林制成,治疗或防止伤口感染,促进伤口愈合。抗菌水凝胶层3释放抗菌成分,对伤口产生抗菌效果,水凝胶保持伤口的湿润环境,避免伤口粘连。. The antibacterial hydrogel 3 of this example is made of biopolymer carrageenan and amoxicillin added to treat or prevent wound infection and promote wound healing. The antibacterial hydrogel layer 3 releases antibacterial ingredients to produce an antibacterial effect on the wound, and the hydrogel maintains the moist environment of the wound to avoid wound adhesion.
抗菌水凝胶层3和吸渗缓冲层4的连接面为相互啮合的齿轮状结构。增加了抗菌水凝胶层3和吸渗缓冲层4的接触面积,创面伤口的渗出液通过抗菌水凝胶层3可以快速的被吸渗缓冲层4吸收,避免渗出液对伤口的污染和对皮肤的浸渍,促进伤口更快愈合。The connection surface of the antibacterial hydrogel layer 3 and the absorbing buffer layer 4 is a gear-like structure that meshes with each other. The contact area between the antibacterial hydrogel layer 3 and the absorption buffer layer 4 is increased, and the exudate of the wound can be quickly absorbed by the absorption buffer layer 4 through the antibacterial hydrogel layer 3 to avoid the contamination of the wound by the exudate. and maceration of the skin to promote faster wound healing.
吸渗缓冲层4为高吸水性树脂制成,透气层5为聚氨酯薄膜制成,背衬层6为医用聚丙烯或无纺布制成的医用胶布,离型纸层1为PET或离型纸片,离型纸层1的尺寸不小于抗菌水凝胶层3的尺寸,离型纸层1可避免敷料在储存过程中遭受污染。在离型纸片中间设有剥离切口7,方便使用时快速撕掉。The absorption buffer layer 4 is made of high water absorbent resin, the breathable layer 5 is made of polyurethane film, the backing layer 6 is medical tape made of medical polypropylene or non-woven fabric, and the release paper layer 1 is PET or release Paper, the size of the release paper layer 1 is not smaller than the size of the antibacterial hydrogel layer 3, and the release paper layer 1 can prevent the dressing from being contaminated during storage. There is a peeling cut 7 in the middle of the release paper sheet, which is convenient for quick tearing off during use.
抗菌水凝胶层3、吸渗缓冲层4、透气层5和背衬层6,其相邻两层之间为胶黏和/或热压的形式复合连接成型。The antibacterial hydrogel layer 3, the absorbing buffer layer 4, the breathable layer 5 and the backing layer 6 are compositely connected and molded in the form of gluing and/or hot pressing between the two adjacent layers.
背衬层6的尺寸不小于透气层5的尺寸,透气层5的尺寸不小于吸渗缓冲层4的尺寸,形成对敷料的保护。优选的,离型纸层1的边缘超出对应的抗菌水凝胶层3应边缘1-2cm。The size of the backing layer 6 is not smaller than the size of the breathable layer 5 , and the size of the breathable layer 5 is not smaller than the size of the absorbent buffer layer 4 to protect the dressing. Preferably, the edge of the release paper layer 1 should exceed the edge of the corresponding antibacterial hydrogel layer 3 by 1-2 cm.
由于复合敷料的每个功能层的厚度会影响其作用功效以及层与层之间配合的作用功效,离型纸层1的厚度为0.1-2mm,填药层2厚度为0.3-1.2mm,抗菌水凝胶层3厚度为1.5-5mm,吸渗缓冲层4的厚度为1-5mm,透气层5厚度为0.5-2mm,背衬层6厚度为0.5-4mm。Since the thickness of each functional layer of the composite dressing will affect its effect and the effect of the cooperation between the layers, the thickness of the release paper layer 1 is 0.1-2mm, the thickness of the filling layer 2 is 0.3-1.2mm, and the antibacterial The thickness of the hydrogel layer 3 is 1.5-5mm, the thickness of the absorption buffer layer 4 is 1-5mm, the thickness of the breathable layer 5 is 0.5-2mm, and the thickness of the backing layer 6 is 0.5-4mm.
本实施例优选的,离型纸层1厚度为0.35mm,填药层2厚度为0.8mm,抗菌水凝胶层3的厚度为2mm,吸渗缓冲层4的厚度为3mm,透气层5的厚度为2mm,背衬层6的厚度为2mm。Preferably in this embodiment, the thickness of the release paper layer 1 is 0.35mm, the thickness of the drug filling layer 2 is 0.8mm, the thickness of the antibacterial hydrogel layer 3 is 2mm, the thickness of the absorption buffer layer 4 is 3mm, and the thickness of the breathable layer 5 is 3mm. The thickness is 2 mm, and the thickness of the backing layer 6 is 2 mm.
本实用新型的新型水凝胶复合敷料,具有良好吸水锁水能力,无需频繁更换,及时处理伤口渗出液,同时具有良好的抗菌能力,保持创面湿润环境,并能促进伤口愈合,减少伤疤的形成。The novel hydrogel composite dressing of the utility model has good water absorption and water retention capacity, does not need to be replaced frequently, treats wound exudate in time, has good antibacterial ability, maintains a moist environment on the wound surface, and can promote wound healing and reduce scars. form.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821735584.7U CN209154217U (en) | 2018-10-25 | 2018-10-25 | A new type of medical hydrogel composite dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201821735584.7U CN209154217U (en) | 2018-10-25 | 2018-10-25 | A new type of medical hydrogel composite dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209154217U true CN209154217U (en) | 2019-07-26 |
Family
ID=67335033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201821735584.7U Expired - Fee Related CN209154217U (en) | 2018-10-25 | 2018-10-25 | A new type of medical hydrogel composite dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209154217U (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613552A (en) * | 2019-10-30 | 2019-12-27 | 江阴市医疗器械有限公司 | Medical dressing formed by compounding |
| CN111685937A (en) * | 2020-06-23 | 2020-09-22 | 江苏省健尔康医用敷料有限公司 | Hemostatic and bactericidal medical dressing and preparation method thereof |
| CN113925684A (en) * | 2021-11-11 | 2022-01-14 | 浙江大学 | Prevent special application of internal fistula infection |
| CN116271180A (en) * | 2023-03-23 | 2023-06-23 | 北京康宇建医疗器械有限公司 | Burn dressing |
-
2018
- 2018-10-25 CN CN201821735584.7U patent/CN209154217U/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110613552A (en) * | 2019-10-30 | 2019-12-27 | 江阴市医疗器械有限公司 | Medical dressing formed by compounding |
| CN111685937A (en) * | 2020-06-23 | 2020-09-22 | 江苏省健尔康医用敷料有限公司 | Hemostatic and bactericidal medical dressing and preparation method thereof |
| CN113925684A (en) * | 2021-11-11 | 2022-01-14 | 浙江大学 | Prevent special application of internal fistula infection |
| CN116271180A (en) * | 2023-03-23 | 2023-06-23 | 北京康宇建医疗器械有限公司 | Burn dressing |
| CN116271180B (en) * | 2023-03-23 | 2024-11-01 | 北京康宇建医疗器械有限公司 | Burn dressing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN209154217U (en) | A new type of medical hydrogel composite dressing | |
| KR20120003231U (en) | Wound dressing using carboxymethyl cellulose fiber | |
| CN104383585B (en) | A kind of three-dimensional manometer composite adhesive bandage and preparation and application thereof | |
| CN204931986U (en) | A kind of high-hygroscopicity antibacterial anti-sticking medical dressing | |
| CN204655268U (en) | A kind of alginate medical dressing | |
| CN201333128Y (en) | Heath care adhesive bandage | |
| CN207575472U (en) | A kind of antibacterial anti hemorrhagic combine dressing | |
| CN205181614U (en) | Dressing of compound biological activity fibre | |
| CN202682163U (en) | Double-layer hydrocolloid medical dressing | |
| CN206792706U (en) | A kind of external application bleeding-stopping dressing | |
| CN218165488U (en) | Medical adhesive plaster for nursing in burn department | |
| CN110755202A (en) | Hydrogel antibacterial gauze dressing | |
| CN204364240U (en) | Tiny structure super-absorbent wound dressing | |
| CN211750457U (en) | Mucous membrane absorbable double-sided adhesive tape | |
| CN201578446U (en) | Alginate foam dressing | |
| CN204744614U (en) | Antibacterial woundplast of anion | |
| CN219127053U (en) | Wound protection application | |
| CN204521200U (en) | For wrapping up the potent adhesive bandage of linear wound | |
| CN205286702U (en) | Burn infects special dressing of surface of a wound | |
| CN219127052U (en) | Medical dressing plaster | |
| CN204971861U (en) | Can keep dry and comfortable woundplast of wound | |
| CN220967514U (en) | Hydrocolloid pressure sore paster | |
| CN215689057U (en) | Chitosan hemostatic sponge dressing | |
| CN211460834U (en) | Separable dressing with multiple composite layers | |
| CN217409384U (en) | A woundplast containing silk fibroin hemostatic powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190726 Termination date: 20211025 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |